Accordingly, the IL-9 neutralization early in infection ameliorates inflammation and restores epithelial homeostasis suggesting a potential therapeutic use of IL-9 neutralizing antibody in the treatment of Candida infection. The gene discussed is IL9; the disease is candidiasis.